[go: up one dir, main page]

IL308068A - Method of titrating dose of psychedelics - Google Patents

Method of titrating dose of psychedelics

Info

Publication number
IL308068A
IL308068A IL308068A IL30806823A IL308068A IL 308068 A IL308068 A IL 308068A IL 308068 A IL308068 A IL 308068A IL 30806823 A IL30806823 A IL 30806823A IL 308068 A IL308068 A IL 308068A
Authority
IL
Israel
Prior art keywords
psychedelics
titrating
dose
titrating dose
Prior art date
Application number
IL308068A
Other languages
Hebrew (he)
Inventor
Robert Barrow
Daniel R Karlin
Original Assignee
Mind Medicine Inc
Robert Barrow
Daniel R Karlin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mind Medicine Inc, Robert Barrow, Daniel R Karlin filed Critical Mind Medicine Inc
Publication of IL308068A publication Critical patent/IL308068A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measurement Of Radiation (AREA)
  • Dental Preparations (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL308068A 2021-05-03 2022-05-01 Method of titrating dose of psychedelics IL308068A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163183579P 2021-05-03 2021-05-03
PCT/US2022/027179 WO2022235529A1 (en) 2021-05-03 2022-05-01 Method of titrating dose of psychedelics

Publications (1)

Publication Number Publication Date
IL308068A true IL308068A (en) 2023-12-01

Family

ID=83932279

Family Applications (1)

Application Number Title Priority Date Filing Date
IL308068A IL308068A (en) 2021-05-03 2022-05-01 Method of titrating dose of psychedelics

Country Status (7)

Country Link
EP (1) EP4333979A4 (en)
JP (1) JP2024517194A (en)
AU (2) AU2022268891A1 (en)
CA (1) CA3216939A1 (en)
IL (1) IL308068A (en)
TW (1) TW202245767A (en)
WO (1) WO2022235529A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL297861A (en) 2020-05-08 2023-01-01 Psilera Inc New compositions of pharmaceutical substances and preparations
MX2023013928A (en) 2021-05-25 2023-12-08 Atai Therapeutics Inc NEW SALTS AND CRYSTALLINE FORMS OF N,N-DIMETHYLTRYPTAMINE SALTS.
JP2024522174A (en) 2021-06-09 2024-06-11 アタイ セラピューティクス， インコーポレイテッド Novel prodrugs and conjugates of dimethyltryptamine
CA3229363A1 (en) 2021-08-20 2023-02-23 Nicholas KADYSH Compositions comprising non-racemic mixtures of (r)- and (s)-3,4-methylenedioxymethamphetamine or (r) and (s) n-methyl-1,3-benzodioxolylbutanamine and uses thereof
US12012381B2 (en) 2021-12-30 2024-06-18 Atai Therapeutics, Inc. Dimethyltryptamine analogues as nitric oxide delivery drugs
EP4486448A1 (en) 2022-03-04 2025-01-08 Reset Pharmaceuticals, Inc. Co-crystals or salts comprising psilocin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106573123B (en) * 2014-06-30 2021-08-31 Syqe医药有限公司 Methods, devices and systems for pulmonary delivery of active agents
EP3713568A1 (en) * 2017-10-26 2020-09-30 Consejo Superior de Investigaciones Cientificas (CSIC) Combination product for the treatment of neurological and/or psychiatric disorders
CA3127854A1 (en) * 2019-01-30 2020-08-06 Judith BLUMSTOCK Methods and compositions comprising a 5ht receptor agonist for the treatment of psychological, cognitive, behavioral, and/or mood disorders
US20220071958A1 (en) * 2019-02-22 2022-03-10 GH Research Ireland Limited 5-methoxy-n,n-dimethyltryptamine (5-meo-dmt) for treating depression
WO2021003467A1 (en) * 2019-07-04 2021-01-07 Sw Holdings, Inc. Metered dosing compositions and methods of use of psychedelic compounds

Also Published As

Publication number Publication date
EP4333979A4 (en) 2025-01-15
TW202245767A (en) 2022-12-01
JP2024517194A (en) 2024-04-19
AU2022268891A1 (en) 2023-11-09
WO2022235529A1 (en) 2022-11-10
AU2025217270A1 (en) 2025-08-28
CA3216939A1 (en) 2022-11-10
EP4333979A1 (en) 2024-03-13

Similar Documents

Publication Publication Date Title
IL308068A (en) Method of titrating dose of psychedelics
HUE061482T2 (en) Method of synthesis
PL3980796T3 (en) Method of cyclic coulometry
GB2590601B (en) Method of mass spectrometry
GB2584946B (en) Method of selecting ions
SG10202003054XA (en) Manufacturing method of chips
GB201900971D0 (en) Insole apparatus and method of manufacture thereof
GB201715654D0 (en) Method of treatment
GB201804594D0 (en) Bonegraft substituteand method of manufacture
GB201802839D0 (en) Method of manufacture
SG11202113371VA (en) Method of synthesizing chemical compounds
GB2553390B (en) Method of manufacture
IL287210A (en) Method of treating tumours
IL289811A (en) Method of treating cancer
SG10202007717QA (en) Manufacturing method of packages
GB202015840D0 (en) Method of forming an electrode
GB201905810D0 (en) Method of treatment
GB201911056D0 (en) Treatment of ADD/ADHD
GB201905379D0 (en) Method of epoxidation
GB2561372B (en) Method of producing ions
GB201704816D0 (en) Method of manufacture
GB202106258D0 (en) Method of formulation
ZA201903823B (en) Method of encapsulation
GB202006949D0 (en) Method of formulation
GB201906748D0 (en) Method of formulation